METASTATIC MALIGNANT NEOPLASM IN THE BONE
Clinical trials for METASTATIC MALIGNANT NEOPLASM IN THE BONE explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM IN THE BONE trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM IN THE BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on returning prostate cancer shows promise
Disease control OngoingThis study tests whether combining surgery and radiation can help men whose prostate cancer has returned or spread to a few spots. About 20 participants will receive targeted radiation and/or surgical removal of those spots. The main goal is to see if this approach can significan…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 26, 2026 10:32 UTC
-
Smart scans may boost radiation success in advanced prostate cancer
Disease control OngoingThis study tests whether a special PET scan (PSMA PET) can help pick the right patients for radium-223 (Ra-223) radiation therapy. Ra-223 targets bone tumors in men with castration-resistant prostate cancer that has spread to the bones. The goal is to see if using the scan leads …
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 10:32 UTC
-
Radioactive drug combo shows promise against bone metastases in breast cancer trial
Disease control OngoingThis study tests whether adding a radioactive drug (radium-223) to standard chemotherapy (paclitaxel) helps people with advanced breast cancer that has spread to their bones. The radioactive drug targets bone tumors specifically, while chemo works throughout the body. About 70 pa…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
New combo shows promise in advanced kidney cancer trial
Disease control OngoingThis phase 3 trial tests whether adding the drug cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with kidney cancer that has spread will take part. The goal is to see if the combination wor…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:24 UTC
-
Could a radioactive drug plus standard therapy ease bone pain in advanced kidney cancer?
Disease control OngoingThis study tests whether adding a radioactive drug (radium-223) to the usual treatment (cabozantinib) helps people with advanced kidney cancer that has spread to the bones. About 134 adults with any type of kidney cancer and bone metastases will be randomly assigned to receive ca…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Could a shot of radiation stop bone fractures before they start?
Disease control OngoingThis study tests whether giving radiation therapy to high-risk but painless bone tumors can prevent future fractures, spinal cord pressure, or the need for surgery. About 280 cancer patients with multiple metastases will receive either usual care (like bone-strengthening drugs or…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a targeted drug boost chemo for aggressive bone cancer?
Disease control OngoingThis study tests whether adding a drug called ganitumab to standard chemotherapy helps people with newly diagnosed Ewing sarcoma that has spread. The trial includes 312 participants and aims to see if the combination improves how long the cancer stays away. This is a phase 3 stud…
Matched conditions: METASTATIC MALIGNANT NEOPLASM IN THE BONE
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:52 UTC